CV/COS Webinar: Clip 16

During the insightful discussion, the potential use of real-world data for a synthetic control arm in clinical trials was explored. Carevive’s commitment to adhering to regulatory standards for electronic data capture sets a strong foundation for future opportunities in optimizing this data for regulatory interactions. While no definitive commitments can be made, the increasing patient numbers and rigorous methods prioritized by Carevive offer hope for real-world data to play a significant role in regulatory decision-making. Collaborating with Aaron and his team, Carevive aims to contribute to the advancement of oncology research and elevate patient outcomes through the integration of real-world evidence.

Recent Episodes

Economic mobility is often portrayed as a straight climb. In reality, it’s shaped by adversity, identity, and access to opportunity. As research from the University of Michigan notes, mobility requires not only income, education, and employment, but also more intangible resources such as social inclusion and power—the ability to make choices and exert influence….

The U.S. healthcare system is strained by rising costs, uneven quality, and fragmented care navigation. Employers are bearing the brunt, spending more without always securing better care for their teams. According to the RAND Corporation, one effective strategy is to “change their network and benefit designs to encourage patients to use lower‑priced, higher‑value providers…

Generative AI has captured the public imagination, but its most transformative use cases may lie far from flashy consumer tools. In healthcare operations, where complexity, inefficiency, and fragmentation remain persistent challenges, AI is now driving measurable improvements. Research suggests AI-enabled healthcare systems could cut administrative costs by up to $360 billion in the U.S. alone….